All_DT Small_NP Nuclear_NP RNAs_NP (_( snRNAs_NP )_) of_IN the_NP [_SYM U4/U6.U5_NP ]_SYM Tri-snRNP_NP Localize_NP to_TO Nucleoli_NP ;_: Identification_NN of_IN the_DT Nucleolar_NP Localization_NP Element_NP of_IN U6_NP snRNA_NP Previously_RB ,_, we_PP showed_VBD that_IN spliceosomal_JJ U6_NP small_JJ nuclear_JJ RNA_NP (_( snRNA_NP )_) transiently_RB passes_VBZ through_IN the_DT nucleolus_NN ._SENT Herein_RB ,_, we_PP report_VBP that_IN all_DT individual_JJ snRNAs_NNS of_IN the_NP [_SYM U4/U6.U5_NP ]_SYM tri-snRNP_NN localize_VB to_TO nucleoli_NNS ,_, demonstrated_VBN by_IN fluorescence_NN microscopy_NN of_IN nucleolar_JJ preparations_NNS after_IN injection_NN of_IN fluorescein-labeled_JJ snRNA_NN into_IN Xenopus_NP oocyte_NN nuclei_NNS ._SENT Nucleolar_JJ localization_NN of_IN U6_NP is_VBZ independent_JJ from_IN [_SYM U4/U6_NP ]_SYM snRNP_JJ formation_NN since_IN sites_NNS of_IN direct_JJ interaction_NN of_IN U6_NP snRNA_NP with_IN U4_NP snRNA_NNS are_VBP not_RB nucleolar_JJ localization_NN elements_NNS ._SENT Among_IN all_DT regions_NNS in_IN U6_NP ,_, the_DT only_JJ one_CD required_VBN for_IN nucleolar_JJ localization_NN is_VBZ its_PP$ 3_CD '_POS end_NN ,_, which_WDT associates_VBZ with_IN the_DT La_NP protein_NN and_CC subsequently_RB during_IN maturation_NN of_IN U6_NP is_VBZ bound_VBN by_IN Lsm_NN proteins_NNS ._SENT This_DT 3'-nucleolar_JJ localization_NN element_NN of_IN U6_NP is_VBZ both_DT essential_JJ and_CC sufficient_JJ for_IN nucleolar_JJ localization_NN and_CC also_RB required_VBN for_IN localization_NN to_TO Cajal_JJ bodies_NNS ._SENT Conversion_NN of_IN the_DT 3_CD '_POS hydroxyl_NN of_IN U6_NP snRNA_NP to_TO a_DT 3_CD '_POS phosphate_NN prevents_VBZ association_NN with_IN the_DT La_NP protein_NN but_CC does_VBZ not_RB affect_VB U6_JJ localization_NN to_TO nucleoli_NNS or_CC Cajal_JJ bodies_NNS ._SENT The_DT nucleolus_NN is_VBZ the_DT site_NN of_IN ribosome_NN biogenesis_NN (_( for_IN review_NN ,_, see_VBP )_) ._SENT However_RB ,_, the_DT nucleolus_NN seems_VBZ to_TO be_VB plurifunctional_JJ and_CC contains_VBZ RNA_NP used_VBN for_IN other_JJ events_NNS ,_, such_JJ as_IN the_DT RNA_NP component_NN of_IN RNase_NP P_NN ,_, which_WDT catalyzes_VBZ the_DT 5_CD '_POS processing_NN of_IN pre-tRNA_NN ,_, signal_NN recognition_NN particle_NN RNA_NP that_WDT assembles_VBZ with_IN proteins_NNS in_IN the_DT nucleolus_NN and_CC telomerase_NN RNA_NP ._SENT Recently_RB ,_, it_PP has_VBZ been_VBN reported_VBN that_IN several_JJ of_IN the_DT small_JJ nuclear_JJ RNAs_NP (_( snRNAs_NP )_) pass_VBP through_IN the_DT nucleolus_NN before_IN their_PP$ nucleoplasmic_JJ destination_NN where_WRB splicing_VBG occurs_VBZ ._SENT U6_NP snRNA_NP transiently_RB localizes_VBZ to_TO nucleoli_NNS where_WRB it_PP seems_VBZ to_TO undergo_VB 2'-O-methylation_JJ and_CC pseudouridylation_NN of_IN defined_VBN nucleotides_NNS ,_, guided_VBN by_IN small_JJ nucleolar_JJ RNAs_NP (_( snoRNAs_NP )_) ._SENT Similarly_RB ,_, U2_NP snRNA_NP is_VBZ found_VBN in_IN nucleoli_NNS where_WRB it_PP seems_VBZ to_TO be_VB modified_VBN by_IN guide_NN snoRNAs_NNS ,_, probably_RB after_IN reimport_NN to_TO the_DT nucleus_NN from_IN the_DT cytoplasm_NN ._SENT In_IN addition_NN ,_, guide_NN snoRNAs_NNS for_IN modification_NN of_IN several_JJ spliceosomal_JJ snRNAs_NNS have_VBP also_RB been_VBN identified_VBN ._SENT In_IN this_DT report_NN ,_, we_PP present_VBP direct_JJ evidence_NN that_IN two_CD of_IN the_DT targets_NNS of_IN modification_NN ,_, U4_NP and_CC U5_NP snRNAs_NNS ,_, localize_VBP to_TO nucleoli_NNS ._SENT Therefore_RB ,_, the_DT list_NN of_IN snRNAs_NNS associated_VBN with_IN nucleoli_NNS is_VBZ expanded_VBN to_TO U6_NP ,_, U2_NP ,_, and_CC U4_NP and_CC U5_NP snRNAs_NNS (_( this_DT report_NN )_) ._SENT The_DT observation_NN of_IN nucleolar_JJ localization_NN of_IN U6_NP snRNA_NP raises_VBZ the_DT question_NN at_IN which_WDT point_NN of_IN its_PP$ life_NN cycle_NN U6_NP enters_VBZ the_DT nucleolus_NN ._SENT Upon_IN transcription_NN by_IN RNA_NP polymerase_NN III_NP ,_, the_DT first_JJ protein_NN to_TO associate_NN with_IN U6_NP snRNA_NP is_VBZ La_NP ,_, which_WDT generally_RB binds_VBZ to_TO the_DT 3_CD '_POS termini_NNS of_IN nascent_JJ RNA_NP polymerase_NN III_NP transcripts_NNS and_CC a_DT number_NN of_IN viral_JJ RNAs_NP ._SENT Subsequently_RB ,_, the_DT 3'-poly_JJ U_NP end_NN of_IN U6_NP elongates_VBZ during_IN maturation_NN and_CC then_RB is_VBZ trimmed_VBN to_TO approximately_RB five_CD uridines_NNS with_IN conversion_NN of_IN the_DT 3_CD '_POS end_NN of_IN U6_NP snRNA_NP from_IN a_DT hydroxyl_NN group_NN to_TO a_DT 2',3'-cyclic_JJ phosphate_NN ._SENT At_IN this_DT point_NN ,_, La_NP is_VBZ replaced_VBN by_IN the_DT evolutionarily_RB conserved_VBN Sm-like_JJ (_( Lsm_NN )_) proteins_VBZ Lsm_NP 2_CD --_: 8_CD ,_, which_WDT facilitate_VBP the_DT formation_NN of_IN the_NP [_SYM U4/U6_NP ]_SYM di-snRNP_NN ._SENT The_DT Lsm_NN proteins_NNS are_VBP specific_JJ in_IN their_PP$ binding_NN to_TO U6_NP snRNA_NN and_CC do_VBP not_RB associate_VB with_IN U1_NP ,_, U2_NP ,_, U4_NP ,_, or_CC U5_NP snRNAs_NNS that_WDT instead_RB are_VBP bound_VBN by_IN Sm_NN proteins_NNS ._SENT Then_RB ,_, the_DT [_SYM U4/U6.U5_NP ]_SYM tri-snRNP_JJ forms_NNS to_TO which_WDT Lsm2-Lsm8_NP and_CC other_JJ proteins_NNS are_VBP associated_VBN ,_, and_CC the_DT use_NN of_IN U6_NP snRNA_NP in_IN the_DT nucleoplasm_NN for_IN splicing_VBG ensues_VBZ ._SENT The_DT experiments_NNS presented_VBD herein_RB demonstrate_VB that_IN the_DT 3_CD '_POS end_NN of_IN U6_NP ,_, which_WDT in_IN vivo_JJ associates_NNS with_IN the_DT La_NP protein_NN and_CC subsequently_RB with_IN the_DT Lsm_NN protein_NN complex_JJ to_TO form_VB the_DT [_SYM U4/U6.U5_NP ]_SYM tri-snRNP_NN ,_, is_VBZ essential_JJ for_IN nucleolar_JJ localization_NN as_RB well_RB as_IN localization_NN to_TO Cajal_NP (_( coiled_VBN )_) bodies_NNS but_CC not_RB for_IN assembly_NN with_IN U4_NP snRNA_NP ._SENT Furthermore_RB ,_, by_IN alteration_NN of_IN the_DT 3_CD '_POS end_NN of_IN U6_NP snRNA_NP ,_, we_PP can_MD exclude_VB the_DT possibility_NN that_IN La_NP plays_VBZ a_DT role_NN in_IN localization_NN of_IN U6_NP to_TO the_DT nucleolus_NN or_CC to_TO Cajal_JJ bodies_NNS ._SENT In_IN addition_NN ,_, we_PP demonstrate_VBP that_IN all_DT snRNAs_NNS of_IN the_NP [_SYM U4/U6.U5_NP ]_SYM tri-snRNP_NN localize_VB to_TO nucleoli_NNS ._SENT In_IN Vitro_NP Transcription_NP and_CC Labeling_NP of_IN RNA_NP |_SYM In_IN vitro_NN transcription_NN reactions_NNS using_VBG polymerase_NN chain_NN reaction_NN (PCR)-generated_JJ DNA_NP templates_NNS produced_VBD the_DT labeled_VBN RNAs_NP used_VBN in_IN the_DT present_JJ study_NN ._SENT The_DT templates_NNS and_CC primers_NNS used_VBN for_IN PCR_NP are_VBP given_VBN below_RB ._SENT Templates_NNS ._SENT |_SYM The_DT starting_VBG material_NN for_IN the_DT template_NN for_IN in_IN vitro_NN transcription_NN of_IN U6_NP snRNA_NP was_VBD the_DT human_JJ U6_NP clone_NN pT7U6_NN ,_, which_WDT carries_VBZ a_DT U6_NP gene_NN that_WDT is_VBZ identical_JJ in_IN sequence_NN to_TO Xenopus_NP tropicalis_NNS except_IN for_IN a_DT one_CD base_NN difference_NN at_IN nucleotide_NN (_( nt_NN )_) 6_CD ._SENT An_DT appropriate_JJ 5_CD '_POS primer_NN was_VBD used_VBN to_TO give_VB a_DT PCR_NP product_NN identical_JJ to_TO the_DT Xenopus_NP U6_NP snRNA_NP gene_NN sequence_NN ,_, as_RB described_VBN previously_RB ;_: this_DT was_VBD subcloned_VBN into_IN pCR3.1_JJ (_( Invitrogen_NP ,_, Carlsbad_NP ,_, CA_NP )_) and_CC its_PP$ sequence_NN was_VBD confirmed_VBN ._SENT The_DT template_NN and_CC primers_NNS for_IN wild-type_NN (_( WT_NP )_) U6_NP snRNA_NP have_VBP been_VBN described_VBN in_RP ._SENT The_DT primers_NNS to_TO generate_VB templates_NNS by_IN PCR_NP for_IN in_IN vitro_NN transcription_NN of_IN mutant_JJ U6_NP snRNA_NN and_CC of_IN wild-type_NN U4_NP or_CC U5_NP snRNA_NP are_VBP listed_VBN below_RB ._SENT Clones_NNS containing_VBG the_DT genes_NNS for_IN Xenopus_NP laevis_NP U5_NP snRNA_NN and_CC chicken_NN U4B_NP snRNA_NP were_VBD kindly_RB provided_VBN by_IN I.W._NP Mattaj_NP (_( European_NP Molecular_NP Biology_NP Laboratory_NP ,_, Heidelberg_NP ,_, Germany_NP )_) in_IN the_DT pUC9_JJ plasmid_NN ;_: the_DT corresponding_JJ snRNAs_NNS were_VBD used_VBN in_IN this_DT study_NN because_IN their_PP$ structure_NN --_: function_NN relationships_NNS were_VBD previously_RB extensively_RB characterized_VBN in_IN Xenopus_NP oocytes_NNS ._SENT Transcripts_NNS of_IN U3_NP snoRNA_NP were_VBD prepared_VBN as_IN described_VBN previously_RB ._SENT A_DT triple_JJ repeat_NN of_IN the_DT 3_CD '_POS end_NN of_IN U6_NP snRNA_NP (_( nt_NN 87_CD --_: 107_CD ,_, called_VBN 3'-end_JJ nucleolar_JJ localization_NN element_NN [_SYM NoLE_NP ]_SYM )_) was_VBD generated_VBN by_IN PCR_NP and_CC its_PP$ sequence_NN confirmed_VBD ._SENT This_DT NoLE_NP construct_NN was_VBD generated_VBN using_VBG 5_CD '_'' and_CC 3_CD '_'' primers_NNS listed_VBN below_IN ._SENT The_DT minus_NN strand_NN template_NN was_VBD 5'-TTG_NP CCG_NP AGG_NP AGC_NP TT(A_NP AAA_NP ATA_NP TGG_NP AAC_NP GCT_NP TCA_NP CG)(A_NP AAA_NP ATA_NP TGG_NP AAC_NP GCT_NP TCA_NP CG)(A_NP AAA_NP ATA_NP TGG_NP AAC_NP GCT_NP TCA_NP CG_NP )_) C_NP CCT_NP ATA_NP GTG_NP AGT_NP CGT_NP ATT_NP A-3_NP '_POS ._SENT The_DT first_JJ 14_CD nucleotides_NNS of_IN this_DT oligonucleotide_NN are_VBP derived_VBN from_IN the_DT genomic_JJ sequence_NN that_WDT follows_VBZ the_DT 3_CD '_POS end_NN of_IN the_DT U6_NP snRNA_NN coding_VBG region_NN of_IN X._NP tropicalis_NNS ._SENT The_DT 21_CD nt_NNS shown_VBN in_IN parentheses_NNS and_CC repeated_VBD three_CD times_NNS are_VBP complementary_JJ to_TO nt_RB 87_CD --_: 107_CD at_IN the_DT 3_CD '_POS end_NN of_IN U6_NP snRNA_NP ._SENT The_DT nt_NN in_IN italics_NNS are_VBP the_DT first_JJ 18_CD nucleotides_NNS of_IN the_DT T7_JJ promotor_NP ._SENT Restriction_NN of_IN the_DT 3'-end_JJ PCR_NP template_NN with_IN MseI_NP (_( site_NN is_VBZ underlined_VBN above_IN )_) removed_VBD the_DT genomic_JJ sequence_NN flanking_VBG the_DT gene_NN ;_: subsequent_JJ in_IN vitro_NN transcription_NN produced_VBD the_DT 65-nt_JJ 3'-end_JJ RNA_NP construct_NN (_( triple_JJ repeat_NN preceded_VBN by_IN GG_NP from_IN the_DT T7_JJ promoter_NN )_) ._SENT The_DT 3'-end_JJ NoLE_NN construct_NN just_RB described_VBN was_VBD also_RB tested_VBN for_IN nucleolar_JJ localization_NN in_IN a_DT heterologous_JJ context_NN by_IN coupling_VBG it_PP to_TO the_DT 3_CD '_POS end_NN of_IN a_DT synthetic_JJ control_NN RNA_NP ._SENT The_DT template_NN for_IN this_DT construct_NN (_( control_VB RNA/3_NP '_POS end_NN )_) was_VBD created_VBN by_IN annealing_VBG (_( complementary_JJ sequences_NNS are_VBP underlined_VBN )_) and_CC PCR_NP extension_NN of_IN the_DT following_VBG two_CD oligonucleotides_NNS :_: 5'-TAA_NP TAC_NP GAC_NP TCA_NP CTA_NP TAG_NP GGT_NP CCT_NP GTC_NP GAC_NP TCC_NP TCC_NP TCC_NP TCC_NP TCC_NP TCC_NP GCG_NP GAT_NP TTA_NP CCT_NP CGG_NP CAA_NP CGT-3_NP '_POS and_CC 5'-TAA_NP ATG_NP AGG_NP AGC_NP TT(A_NP AAA_NP ATA_NP TGG_NP AAC_NP GCT_NP TCA_NP CG)(A_NP AAA_NP ATA_NP TGG_NP AAC_NP GCT_NP TCA_NP CG)(A_NP AAA_NP ATA_NP TGG_NP AAC_NP GCT_NP TCA_NP CG)T_NP TGC_NP CGA_NP GGT_NP AAA_NP TCC_NP GCG_NP GA-3_NP '_'' ;_: the_DT T7_JJ promotor_NP is_VBZ shown_VBN in_IN italics_NNS and_CC the_DT 3'-end_JJ NoLE_NN (_( nt_RB 87_CD --_: 107_LS )_) repeated_VBN three_CD times_NNS are_VBP enclosed_VBN by_IN parentheses_NNS ._SENT The_DT synthetic_JJ control_NN RNA_NP by_IN itself_PP was_VBD created_VBN by_IN PCR_NP by_IN using_VBG the_DT template_NN and_CC primers_NNS described_VBD by_IN ._SENT U2_NP snRNA_NP was_VBD used_VBN as_IN a_DT control_NN for_IN immunoprecipitation_NN experiments_NNS and_CC stability_NN assays_NNS and_CC was_VBD derived_VBN as_IN described_VBN previously_RB ._SENT 5_LS '_POS End_NP Primers_NP (_( T7_NP Promotor_NP Shown_NP in_IN Italics_NNS )_) ._SENT |_SYM U4_NP WT_NP 5'-TAA_NP TAC_NP GAC_NP TCA_NP CTA_NP TAG_NP GGA_NP GCT_NP TTG_NP CGC_NP AGT_NP GGC_NP AGT_NP ATC-3_NP '_'' ;_: U5_NP WT_NP 5'-TAA_NP TAC_NP GAC_NP TCA_NP CTA_NP TAG_NP GGA_NP TAC_NP TCT_NP GGT_NP TTC_NP TCT_NP TCA_NP AAT_NP TCG_NP AAT_NP AAA_NP TC-3_NP '_'' ;_: U6_NP Delta1_NP --_: 19_CD 5'-TAA_NP TAC_NP GAC_NP TCA_NP CTA_NP TAG_NP GGA_NP TAT_NP ACT_NP AAA_NP ATT_NP GGA-3_NP '_'' ;_: U6_NP Delta20_NP --_: 25_CD 5'-TAA_NP TAC_NP GAC_NP TCA_NP CTA_NP TAG_NP GGT_NP GCT_NP TGC_NP TTC_NP GGC_NP AGC_NP ACT_NP AAA_NP ATT_NP GG-3_NP '_'' ;_: U6_NP sub20_NP --_: 25_CD (_( substitution_NN is_VBZ underlined_VBN )_) 5'-TAA_NP TAC_NP GAC_NP TCA_NP CTA_NP TAG_NP GGT_NP GCT_NP TGC_NP TTC_NP GGC_NP AGC_NP ACG_NP AGC_NP GGT_NP AAA_NP ATT_NP GG-3_NP '_'' ;_: U6_NP Delta26_NP --_: 42_CD 5'-TAA_NP TAC_NP GAC_NP TCA_NP CTA_NP TAG_NP GGT_NP GCT_NP TGC_NP TTC_NP GGC_NP AGC_NP ACA_NP TAT_NP ACA_NP GAG_NP AAG_NP AT-3_NP '_'' ;_: and_CC T7_JJ promoter_NN for_IN 3'-end_JJ construct_NN 5'-TAA_NP TAC_NP GAC_NP TCA_NP CTA_NP TAG_NP GG-3_NP '_POS ._SENT 3_LS '_POS End_NP Primers_NP ._SENT |_SYM U4_NP WT_NP 5'-CAG_NP TCT_NP CCG_NP TAG_NP AGA_NP CTG_NP TCA-3_NP '_'' ;_: U5_NP WT_NP 5'-TAC_NP CTG_NP GTG_NP TGA_NP ACC_NP AGG_NP CTT_NP C-3_NP '_'' ;_: U6_NP Delta43_NP --_: 56_CD 5'-AAA_NP AAT_NP ATG_NP GAA_NP CGC_NP TTC_NP ACG_NP AAT_NP TTG_NP CGT_NP GTC_NP ATC_NP CTT_NP GCG_NP CAG_NP GGG_NP CCA_NP GTA_NP TCG_NP TTC_NP C-3_NP '_'' ;_: U6_NP Delta57_NP --_: 81_CD 5'-AAA_NP AAT_NP ATG_NP GAA_NP CGC_NP TTC_NP ACG_NP AAT_NP TTT_NP GCT_NP AAT_NP CTT-3_NP '_'' ;_: U6_NP Delta43_NP --_: 81_CD 5'-AAA_NP AAT_NP ATG_NP GAA_NP CGC_NP TTC_NP ACG_NP AAT_NP TTG_NP TAT_NP CGT_NP TCC-3_NP '_'' ;_: U6_NP Delta82_NP --_: 95_CD 5'-AAA_NP AAT_NP ATG_NP GAA_NP GCG_NP TGT_NP CAT_NP CCT_NP TGC-3_NP '_'' ;_: U6_NP Delta96_NP --_: 99_CD 5'-AAA_NP AAT_NP ATC_NP GCT_NP TCA_NP CGA_NP ATT_NP T-3_NP '_'' ;_: U6_NP Delta100_NP --_: 102_CD 5'-AAA_NP AAG_NP GAA_NP CGC_NP TTC_NP ACG_NP AAT_NP TTG_NP CGT_NP GTC_NP ATC_NP CTT_NP G-3_NP '_'' ;_: U6_NP Delta103_NP --_: 107_CD 5'-TAT_NN GGA_NP ACG_NP CTT_NP CAC_NP GAA_NP TTT_NP GCG_NP TGT_NP CAT_NP CCT_NP TG-3_NP '_'' ;_: U6_NP Delta100_NP --_: 107_CD 5'-GGA_NP ACG_NP CTT_NP CAC_NP GAA_NP TTT_NP GCG_NP TGT_NP CAT_NP CCT_NP TG-3_NP '_'' ;_: U6_NP Delta82_NP --_: 107_CD 5'-GCG_NN TGT_NP CAT_NP CCT_NP TGC_NP GCA_NP GGG_NP GCC-3_NP '_'' ;_: and_CC U6_NP 3'-end_JJ 5'-TTG_NP CCG_NP AGG_NP AGC_NP TTA_NP AA-3_NP '_'' (_( genomic_JJ sequence_NN downstream_JJ of_IN U6_NP )_) ._SENT In_IN vitro_NN transcripts_NNS of_IN RNA_NP were_VBD made_VBN with_IN either_DT fluorescein-12-UTP_NN (_( PerkinElmer_NP Life_NP Sciences_NPS ,_, Boston_NP ,_, MA_NP )_) and/or_CC alpha-[32P]UTP_NP (_( PerkinElmer_NP Life_NP Sciences_NPS )_) label_NN that_WDT was_VBD added_VBN to_TO a_DT T7_JJ megascript_NN in_IN vitro_NN transcription_NN kit_NN (_( Ambion_NP ,_, Austin_NP ,_, TX_NP )_) ._SENT The_DT T7_JJ transcripts_NNS were_VBD purified_VBN according_VBG to_TO ._SENT They_PP all_RB contained_VBD GG_NP at_IN their_PP$ 5_CD '_POS ends_NNS from_IN the_DT T7_JJ promoter_NN and_CC were_VBD capped_VBN with_IN m7G(5')ppp(5')G_NN (_( Ambion_NP )_) to_TO improve_VB stability_NN ._SENT Oocyte_NN Microinjection_NN |_SYM Stage_NP V-VI_NP oocytes_NNS from_IN X._NP laevis_NP were_VBD obtained_VBN as_IN described_VBN previously_RB ._SENT For_IN fluorescence_NN analysis_NN of_IN nucleolar_JJ localization_NN as_IN well_RB as_RB for_IN stability_NN assays_NNS ,_, oocyte_NN nuclei_NNS were_VBD injected_VBN with_IN 0.8_CD ng_NNS of_IN wild-type_NP U4_NP ,_, U5_NP ,_, and_CC U6_NP snRNA_NP or_CC U3_NP snoRNA_NP in_IN 9.2_CD nl_NN of_IN H2O_NP ._SENT For_IN the_DT U6_NP snRNA_NN mutants_NNS that_WDT were_VBD shorter_JJR than_IN the_DT wild-type_NN and_CC for_IN the_DT 3'-end_JJ construct_NN ,_, amounts_VBZ equimolar_NN to_TO the_DT wild-type_NN U6_NP RNA_NP (_( 0.8_CD ng_NNS =_SYM similar23_JJ fmol_NN of_IN in_IN vitro-transcribed_JJ WT_NP U6_NP snRNA_NP )_) were_VBD injected_VBN ._SENT The_DT concentration_NN of_IN U6_NP used_VBN for_IN injection_NN was_VBD determined_VBN by_IN titration_NN to_TO be_VB the_DT lowest_JJS possible_JJ that_IN still_RB gave_VBD specific_JJ labeling_VBG of_IN nucleoli_NNS (_( our_PP$ unpublished_JJ data_NNS )_) and_CC is_VBZ in_IN the_DT range_NN of_IN the_DT concentration_NN of_IN endogenous_JJ U6_NP (_( similar7.5_NN fmol/stage_NN V-VI_NP oocyte_NN as_IN determined_VBN by_IN Northern_JJ blot_NN analysis_NN )_) ,_, whereas_IN there_EX is_VBZ nuclear_JJ retention_NN of_IN up_RB to_TO similar500_NN --_: 600_CD fmol_NN of_IN U6_NP per_IN Xenopus_NP oocyte_NN ._SENT The_DT concentration_NN used_VBN for_IN injection_NN of_IN our_PP$ transcripts_NNS is_VBZ also_RB in_IN the_DT range_NN of_IN those_DT used_VBN by_IN for_IN oocyte_NN injection_NN of_IN U1_NP ,_, U2_NP ,_, and_CC U5_NP snRNA_NP ._SENT For_IN the_DT 40-nt_JJ negative_JJ control_NN RNA_NP ,_, 0.8_CD ng/oocyte_NNS was_VBD injected_VBN ,_, which_WDT is_VBZ equivalent_JJ to_TO similar62_JJ fmol/oocyte_NN ._SENT A_DT further_JJR control_NN was_VBD the_DT injection_NN of_IN an_DT excess_NN of_IN fluorescein-labeled_JJ UTP_NN at_IN 5_CD pmol/oocyte_NN ._SENT We_PP confirmed_VBD that_IN microinjected_JJ U4_NP and_CC U6_NP snRNA_NP transcripts_NNS could_MD participate_VB in_IN their_PP$ normal_JJ functional_JJ pathway_NN and_CC form_VB a_DT di-snRNP_NN ._SENT This_DT was_VBD achieved_VBN by_IN coimmunoprecipitation_NN (_( see_VB section_VB below_IN )_) with_IN an_DT anti-Sm_NN antibody_NN as_RB described_VBD previously_RB ._SENT Endogenous_JJ U6_NP and_CC U4_NP snRNA_NP were_VBD disrupted_VBN through_IN RNase_NP H-mediated_NP destruction_NN by_IN two_CD nuclear_JJ injections_NNS spaced_VBD 4_CD h_NN apart_RB of_IN 9.2_CD nl_NN of_IN each_DT of_IN the_DT following_VBG antisense_NN oligonucleotides_NNS at_IN a_DT concentration_NN of_IN 3_CD mug/mul_NN (_( 28_CD ng/oocyte_NNS )_) :_: a_DT combination_NN of_IN two_CD oligonucleotides_NNS complementary_JJ to_TO nt_RB 20_CD --_: 53_NP (_( 5'-TAA_NP TCT_NP TCT_NP CTG_NP TAT_NP CGT_NP TCC_NP AAT_NP TTT_NP AGT_NP ATA_NP T-3_NP '_'' )_) and_CC nt_RB 75_CD --_: 102_NP (_( 5'-TAT_NP GGA_NP ACG_NP CTT_NP CAC_NP GAA_NP TTT_NP GCG_NP TGT_NP C-3_NP '_'' )_) was_VBD used_VBN for_IN U6_NP depletion_NN ._SENT U4_JJ depletion_NN was_VBD carried_VBN out_RP with_IN an_DT oligonucleotide_NN complementary_JJ to_TO nt_RB 51_CD --_: 83_NP (_( 5'-GGG_NP TAT_NP TGG_NP GAA_NP AAG_NP TTT_NP TCA_NP ATT_NP AGC_NP AAT_NP A-3_NP '_'' )_) ._SENT Nucleolar_JJ Localization_NP Assay_NP |_SYM After_IN incubation_NN of_IN the_DT oocytes_NNS for_IN a_DT stipulated_VBN time_NN (_( 1.0_CD --_: 1.5_CD h_NN unless_IN specified_VBN otherwise_RB )_) ,_, nuclear_JJ spreads_NNS were_VBD made_VBN as_IN described_VBN previously_RB using_VBG a_DT method_NN for_IN preparation_NN of_IN lampbrush_NN chromosomes_NNS ._SENT For_IN Cajal_JJ body_NN immunostaining_NN ,_, the_DT slides_NNS were_VBD fixed_VBN for_IN 1_CD h_NN in_IN 2_CD %_NN paraformaldehyde_NN in_IN phosphate-buffered_JJ saline_NN (_( PBS_NP )_) (_( 137_CD mM_NP NaCl_NP ,_, 3_CD mM_NP KCl_NP ,_, 6.4_CD mM_NP Na2HPO4_NP ,_, and_CC 1.5_CD mM_NP KH2PO4_NP ,_, pH_NN 7.0_CD )_) ,_, washed_VBN in_IN PBS_NP ,_, and_CC unspecific_JJ binding_JJ sites_NNS saturated_VBN with_IN 10_CD %_NN bovine_JJ serum_NN albumin_NN in_IN PBS_NP for_IN 20_CD min_NN ._SENT Subsequently_RB ,_, rabbit_NN polyclonal_JJ serum_NN against_IN a_DT synthetic_JJ 21_CD amino-acid_JJ fragment_NN of_IN Xenopus_NP coilin_NP (_( kindly_RB provided_VBN by_IN J.G._NP Gall_NP ,_, Carnegie_NP Institution_NP ,_, Baltimore_NP ,_, MD_NP )_) was_VBD applied_VBN as_IN a_DT primary_JJ antibody_NN for_IN immunostaining_NN of_IN Cajal_JJ bodies_NNS at_IN a_DT dilution_NN of_IN 1:1000_CD in_IN PBS_NP for_IN 20_CD min_NN at_IN 4C_JJ ._SENT The_DT preparations_NNS were_VBD rinsed_VBN 3x_JJ for_IN 5_CD min_NN each_DT in_IN PBS_NP and_CC incubated_VBN for_IN 20_CD min_NN at_IN 4C_JJ with_IN the_DT secondary_JJ antibody_NN (_( goat_NN anti-rabbit_NN ;_: Molecular_NP Probes_NP ,_, Eugene_NP ,_, OR_NP )_) coupled_VBD to_TO the_DT dye_NN Alexa_NP 594_CD ._SENT Subsequently_RB ,_, slides_NNS were_VBD washed_VBN 3x_JJ with_IN PBS_NP for_IN 5_CD min_NN each_DT and_CC the_DT DNA_NN stained_VBN with_IN 200_CD ng/ml_NNS 4'-6-diamidino-2-Phenylindole_JJ (_( DAPI_NP )_) in_IN PBS_NP for_IN 5_CD min_NN ._SENT Fluorescence_NN microscopy_NN was_VBD performed_VBN as_IN described_VBN previously_RB with_IN the_DT exception_NN that_IN ProLong_NNS mounting_VBG medium_NN (_( Molecular_NP Probes_NP )_) was_VBD used_VBN ._SENT Nucleolar_JJ preparations_NNS were_VBD analyzed_VBN with_IN an_DT Axiophot_NP epifluorescence_NN microscope_NN (_( Carl_NP Zeiss_NP ,_, Thornwood_NP ,_, NY_NP )_) equipped_VBD with_IN a_DT 100x_NP Neofluar_NP Ph_NN 3_CD objective_NN and_CC a_DT 100-W_JJ mercury_NN lamp_NN ._SENT Pictures_NNS were_VBD taken_VBN with_IN constant_JJ exposures_NNS for_IN each_DT filter_NN set_NN (_( for_IN DAPI_NP ,_, Alexa_NP 594_CD ,_, or_CC fluorescein_NN )_) by_IN using_VBG Ektachrome_NN 400x_JJ professional_JJ film_NN (_( Eastman_NP Kodak_NP ,_, Rochester_NP ,_, NY_NP )_) ._SENT Therefore_RB ,_, any_DT difference_NN in_IN signal_NN strength_NN between_IN various_JJ samples_NNS is_VBZ directly_RB visualized_VBN without_IN the_DT interference_NN of_IN software_NN or_CC automatic_JJ camera_NN settings_NNS ._SENT snoRNA_NP Stability_NP Assay_NP |_SYM To_TO determine_VB the_DT stability_NN of_IN the_DT various_JJ in_IN vitro_NN transcripts_NNS after_IN injection_NN into_IN oocyte_NN nuclei_NNS ,_, U2_NP snRNA_NP was_VBD coinjected_VBN and_CC served_VBN as_IN an_DT internal_JJ control_NN to_TO normalize_VB for_IN any_DT differences_NNS in_IN injection_NN or_CC recovery_NN of_IN the_DT samples_NNS ._SENT At_IN defined_VBN time_NN points_NNS after_IN injection_NN of_IN the_DT oocytes_NNS with_IN [_SYM alpha-32P]UTP_NN --_: labeled_VBN RNAs_NP ,_, the_DT RNA_NP of_IN four_CD nuclei_NNS per_IN sample_NN was_VBD recovered_VBN and_CC analyzed_VBN as_IN described_VBN previously_RB ._SENT Immunoprecipitation_NN of_IN U6_NP snRNA_NP from_IN Oocytes_NP |_SYM For_IN immunoprecipitation_NN experiments_NNS ,_, 0.8_CD ng/oocyte_NNS of_IN the_DT purified_VBN U6_NP snRNA_NP (_( colabeled_VBN with_IN alpha-[32P]UTP_NN and_CC with_IN fluorescein-12-UTP_NN )_) and_CC either_DT 0.8_CD ng/oocyte_NN fluorescein-12-UTP_NN --_: labeled_VBD U4_NP snRNA_NP or_CC alpha-[32P]UTP_NP --_: labeled_VBD U3_NP snoRNA_NP were_VBD coinjected_VBN into_IN Xenopus_NP oocytes_NNS and_CC incubated_VBN for_IN 1_CD or_CC 4_CD h_NN (_( depending_VBG on_IN the_DT experiment_NN )_) at_IN 20C_JJ ._SENT For_IN each_DT sample_NN ,_, 10_CD nuclei_NNS were_VBD homogenized_VBN on_IN ice_NN in_IN 50_CD mul_NN of_IN isolation_NN buffer_NN (_( 50_CD mM_NP NaCl_NP ,_, 10_CD mM_NP Tris_NP pH_NN 8.0_CD ,_, 1_CD mM_NP dithiothreitol_NN ,_, 100_CD U/ml_NP RNase_NP inhibitor_NN [_SYM Roche_NP Applied_NP Science_NP ,_, Mannheim_NP ,_, Germany_NP ]_SYM ,_, one_CD tablet_NN of_IN protease_NN inhibitor_NN cocktail_NN [_SYM Roche_NP Applied_NP Science_NP ]_SYM per_IN 10_CD ml_NN of_IN isolation_NN buffer_NN )_) ,_, and_CC spun_VBN for_IN 1_CD min_NN in_IN a_DT microcentrifuge_NN at_IN 10,000_CD rpm_NN ._SENT The_DT supernatant_JJ was_VBD removed_VBN ,_, spun_VBN again_RB twice_RB ,_, and_CC then_RB added_VBD to_TO 240_CD mul_NN of_IN IP_NP 150_CD (_( 150_CD mM_NP NaCl_NP ,_, 10_CD mM_NP Tris_NP pH_NN 8.0_CD ,_, 0.1_CD %_NN NP-40_NP ,_, 1_CD mM_NP dithiothreitol_NN ,_, 10_CD U/ml_NP RNase_NP inhibitor_NN [_SYM Roche_NP Applied_NP Science_NP ]_SYM ,_, and_CC one_CD tablet_NN of_IN protease_NN inhibitor_NN cocktail_NN [_SYM Roche_NP Applied_NP Science_NP ]_SYM per_IN 10_CD ml_NN of_IN isolation_NN buffer_NN )_) ,_, and_CC 20_CD mul_NN of_IN protein_NN A-Sepharose_NN beads_NNS ._SENT The_DT beads_NNS had_VBD been_VBN coupled_VBN either_RB to_TO rabbit-anti-Xenopus_NP La_NP antibody_NN (_( immune_JJ serum_NN 79_CD ,_, provided_VBN by_IN S._NP Clarkson_NP ,_, University_NP Medical_NP Center-CMU_NP ,_, Geneva_NP ,_, Switzerland_NP ;_: )_) or_CC to_TO preimmune_JJ serum_NN as_IN a_DT control_NN ,_, or_CC in_IN other_JJ cases_NNS to_TO monoclonal_NN Y12_NP mouse_NN anti-Sm_NN antibody_NN or_CC mouse_NN IgG_NP as_IN a_DT control_NN by_IN incubation_NN of_IN 150_CD mul_NN of_IN preswollen_JJ beads_NNS with_IN 150_CD mul_NN of_IN IP_NP 500_CD (_( 500_CD mM_NP NaCl_NP ,_, 10_CD mM_NP Tris_NP pH_NN 8.0_CD ,_, 0.1_CD %_NN NP-40_NN ,_, and_CC 0.1_CD %_NN sodium_NN azide_NN )_) and_CC 200_CD mul_NN of_IN antibody_NN for_IN 4_CD h_NN at_IN 4C_JJ with_IN end_NN over_IN end_NN rotation_NN before_IN they_PP were_VBD spun_VBN and_CC washed_VBN 3x_NN in_IN IP_NP 150_CD in_IN a_DT microcentrifuge_NN at_IN 1000_CD rpm_NN ._SENT The_DT mixture_NN of_IN nuclear_JJ extract_NN and_CC antibody-coupled_JJ beads_NNS was_VBD rotated_VBN end_NN over_IN end_NN for_IN 90_CD min_NN (_( anti-La_NN antibody_NN )_) or_CC 8_CD h_NN (_( anti-Sm_NN antibody_NN )_) at_IN 4C_JJ before_IN the_DT beads_NNS were_VBD spun_VBN and_CC washed_VBN 5x_NN in_IN IP_NP 150_CD in_IN a_DT microcentrifuge_NN at_IN 1000_CD rpm_NN ._SENT Then_RB the_DT RNA_NP was_VBD isolated_VBN and_CC purified_VBN ._SENT Precipitated_VBD RNA_NP and_CC supernatant_JJ were_VBD analyzed_VBN on_IN a_DT denaturing_VBG 7_CD M_NN urea_NN ,_, 8_CD %_NN polyacrylamide_NN gel_NN (_( 1_CD mm_NN in_IN thickness_NN ,_, 35_CD cm_NN in_IN length_NN )_) ._SENT It_PP is_VBZ important_JJ to_TO note_VB that_IN although_IN U4_NP transcript_NN association_NN with_IN Sm_NN proteins_NNS and_CC U6_NP is_VBZ initiated_VBN upon_IN injection_NN into_IN the_DT oocyte_NN ,_, further_JJR association_NN can_MD also_RB occur_VB during_IN coincubation_NN of_IN nuclear_JJ lysate_NNS with_IN antibody-coupled_JJ beads_NNS ._SENT Therefore_RB ,_, accurate_JJ kinetics_NNS of_IN in_IN vivo_JJ association_NN of_IN U4/U6_NP cannot_MD be_VB carried_VBN out_RP ._SENT For_IN alteration_NN of_IN the_DT 3'-hydroxyl_JJ end_NN of_IN U6_NP to_TO a_DT 3'-phosphate_JJ group_NN ,_, 10_CD mul_NN with_IN the_DT in_IN vitro_NN transcript_NN (_( similar1_JJ mug_NN )_) was_VBD incubated_VBN in_IN Whitfield_NP 's_POS reagent_NN (_( 25_CD mM_NP NaIO4_NP and_CC 1_CD M_NN lysine_NN ,_, pH_NN 8.5_CD )_) for_IN 2_CD h_NN at_IN 45C_JJ ._SENT This_DT treatment_NN of_IN oxidation-beta_NN elimination_NN also_RB shortens_VBZ the_DT input_NN RNA_NP by_IN 1_CD nt_NNS ._SENT Nucleolar_JJ Localization_NN of_IN U4_NP and_CC U5_NP snRNA_NP |_SYM U4_JJ snRNA_NN and_CC subsequently_RB U5_NP snRNA_NP and_CC U2_NP snRNA_NP associate_NN with_IN U6_NP to_TO form_VB the_DT [_SYM U4/U6_NP ]_SYM di-snRNP_NN ,_, [_SYM U4/U6.U5_NP ]_SYM tri-snRNP_NN ,_, and_CC [_SYM U2.U4/U6.U5_NP ]_SYM tetra-snRNP_NN ._SENT To_TO complete_VB the_DT picture_NN ,_, we_PP analyzed_VBD whether_IN U4_NP and_CC U5_NP snRNAs_NNS associate_VBP with_IN nucleoli_NNS ,_, like_IN U6_NP and_CC U2_NP ._SENT This_DT was_VBD monitored_VBN by_IN a_DT technique_NN used_VBD previously_RB to_TO define_VB the_DT nucleolar_JJ localization_NN elements_NNS (_( NoLEs_NP )_) of_IN snoRNAs_NNS from_IN various_JJ families_NNS (_( ,_, ,_, ,_, ;_: ,_, )_) as_RB well_RB as_IN nucleolar_JJ localization_NN of_IN U6_NP snRNA_NP ._SENT Fluorescein-labeled_VBN in_IN vitro_NN transcripts_NNS were_VBD injected_VBN into_IN Xenopus_NP oocyte_NN nuclei_NNS to_TO allow_VB direct_JJ visualization_NN of_IN the_DT labeled_VBN RNA_NP in_IN nucleolar_JJ preparations_NNS made_VBN subsequently_RB ._SENT In_IN the_DT present_JJ study_NN ,_, fluorescein-labeled_VBN in_IN vitro_NN transcripts_NNS of_IN U4_NP snRNA_NP and_CC U5_NP snRNA_NP were_VBD injected_VBN into_IN Xenopus_NP oocyte_NN nuclei_NNS ._SENT Controls_NNS included_VBD injection_NN of_IN nucleolar_JJ U3_NP snoRNA_NN as_IN a_DT positive_JJ control_NN ,_, and_CC injection_NN of_IN a_DT 40-nt_JJ synthetic_JJ RNA_NP or_CC fluorescein-UTP_NN as_IN negative_JJ controls_NNS to_TO rule_VB out_RP nonspecific_JJ nucleolar_JJ staining_VBG (_( e.g._FW ,_, by_IN diffusion_NN of_IN excess_JJ material_NN )_) ._SENT After_IN 8_CD min_NN ,_, 1_CD h_NN ,_, and_CC 24_CD h_NN (_( the_DT longest_JJS time_NN point_NN feasible_JJ to_TO be_VB studied_VBN )_) ,_, the_DT oocytes_NNS were_VBD manually_RB dissected_VBN and_CC the_DT nuclear_JJ contents_NNS ,_, including_VBG nucleoli_NNS ,_, were_VBD centrifuged_VBN onto_IN a_DT microscope_NN slide_NN ._SENT As_IN shown_VBN in_IN Figure_NN a_DT ,_, strong_JJ fluorescent_JJ signals_NNS depicting_VBG nucleolar_JJ localization_NN of_IN U4_NP and_CC U5_NP snRNA_NP were_VBD detected_VBN 8_CD min_NN and_CC 1_CD h_NN after_IN injection_NN of_IN 0.8_CD ng_NNS of_IN transcript_NN per_IN oocyte_NN nucleus_NN ._SENT Likewise_RB ,_, nucleoli_NNS were_VBD stained_VBN by_IN a_DT positive_JJ control_NN (_( U3_NP snoRNA_NP )_) ,_, injected_VBN at_IN the_DT same_JJ concentration_NN that_WDT had_VBD been_VBN previously_RB optimized_VBN for_IN the_DT nucleolar_JJ localization_NN assay_NN ._SENT In_IN contrast_NN ,_, negative_JJ controls_NNS (_( 40-nt_JJ synthetic_JJ RNA_NP =_SYM control_NN RNA_NP ,_, or_CC unincorporated_JJ fluorescein-UTP_NN )_) ,_, both_CC injected_VBD in_IN excess_JJ (_( see_VB MATERIALS_NNS AND_CC METHODS_NNS )_) did_VBD not_RB stain_VB nucleoli_NNS ._SENT Twenty-four_NP hours_NNS after_IN incubation_NN ,_, only_RB U3_NP snoRNA_NP retained_VBD strong_JJ signals_NNS in_IN nucleoli_NNS ,_, whereas_IN U4_NP snRNA_NP labeling_VBG was_VBD reduced_VBN and_CC U5_JJ snRNA_NN signals_NNS were_VBD close_JJ to_TO background_NN (_( Figure_NP a_DT )_) ._SENT This_DT observation_NN is_VBZ consistent_JJ with_IN the_DT nucleolus_NN being_VBG the_DT functional_JJ compartment_NN for_IN U3_NP snoRNA_NP and_CC with_IN the_DT predicted_VBN transient_JJ nature_NN of_IN snRNA_NN localization_NN to_TO nucleoli_NNS ,_, as_RB has_VBZ been_VBN already_RB shown_VBN for_IN U6_NP snRNA_NP in_IN the_DT same_JJ system_NN ._SENT Figure_NP 1_CD |_SYM Nucleolar_JJ localization_NN of_IN U4_NP and_CC U5_NP snRNA_NP ._SENT Nucleolar_JJ localization_NN of_IN U4_NP and_CC U5_NP snRNA_NP ._SENT (_( a_DT )_) Fluorescein-labeled_NP U4_NP snRNA_NP or_CC U5_NP snRNA_NP were_VBD injected_VBN into_IN the_DT nuclei_NNS of_IN X._NP laevis_NP oocytes_NNS to_TO analyze_VB nucleolar_JJ localization_NN ._SENT Controls_NNS included_VBD injection_NN of_IN nucleolar_JJ U3_NP snoRNA_NN as_RB well_RB as_IN synthetic_JJ RNA_NP or_CC fluorescein-UTP_NP to_TO rule_VB out_RP nonspecific_JJ nucleolar_JJ staining_VBG ._SENT After_IN 8_CD min_NN ,_, 1_CD h_NN ,_, or_CC 24_CD h_NN ,_, nuclear_JJ spreads_NNS were_VBD prepared_VBN and_CC analyzed_VBN by_IN phase_NN contrast_NN (_( PC_NN )_) or_CC fluorescence_NN microscopy_NN ._SENT Nucleoli_NNS can_MD be_VB distinguished_VBN from_IN other_JJ nonchromosomal_JJ nuclear_JJ bodies_NNS by_IN staining_VBG of_IN the_DT rDNA_NP (_( DAPI_NP ,_, blue_JJ )_) ._SENT Strong_JJ nucleolar_JJ labeling_VBG (_( FL_NP ,_, green_JJ )_) is_VBZ seen_VBN as_IN early_JJ as_IN 8_CD min_NN after_IN nuclear_JJ injection_NN of_IN U4_NP or_CC U5_NP snRNA_NP and_CC continues_VBZ at_IN 1_CD h_NN after_IN injection_NN ._SENT Likewise_RB ,_, nucleoli_NNS were_VBD stained_VBN by_IN a_DT positive_JJ control_NN (_( U3_NP snoRNA_NP )_) at_IN these_DT time_NN points_NNS ,_, whereas_IN negative_JJ controls_NNS (_( control_NN RNA_NP or_CC unincorporated_JJ fluorescein-UTP_NN )_) ,_, both_CC injected_VBD in_IN excess_JJ (_( see_VB MATERIALS_NNS AND_CC METHODS_NNS )_) ,_, did_VBD not_RB stain_VB nucleoli_NNS ._SENT Twenty-four_NP hours_NNS after_IN incubation_NN only_JJ U3_NP snoRNA_NN retains_VBZ strong_JJ signals_NNS in_IN nucleoli_NNS ,_, whereas_IN U4_NP snRNA_NP labeling_VBG is_VBZ reduced_VBN and_CC U5_JJ snRNA_NN signals_NNS are_VBP close_JJ to_TO background_NN ._SENT Stronger_JJR nucleolar_JJ staining_VBG by_IN U4_JJ snRNA_NN compared_VBN with_IN U5_NP snRNA_NP or_CC U6_NP snRNA_NP was_VBD generally_RB observed_VBN at_IN all_DT time_NN points_NNS ._SENT Bar_NP ,_, 10_CD mm_NN ._SENT (_( b_LS )_) 32P-Labeled_JJ transcripts_NNS of_IN U4_NP and_CC U5_NP snRNA_NP were_VBD injected_VBN into_IN oocyte_NN nuclei_NNS to_TO determine_VB their_PP$ stability_NN ;_: the_DT RNAs_NP were_VBD isolated_VBN and_CC analyzed_VBN by_IN gel_NN electrophoresis_NN as_RB described_VBD previously_RB ._SENT U2_JJ snRNA_NN transcripts_NNS were_VBD coinjected_VBN and_CC served_VBN as_IN an_DT internal_JJ control_NN to_TO normalize_VB for_IN any_DT differences_NNS in_IN injection_NN or_CC recovery_NN of_IN the_DT samples_NNS ._SENT U4_NP and_CC U5_NP snRNA_NP are_VBP stable_JJ 24_CD h_NN after_IN oocyte_NN injection_NN ,_, compared_VBN to_TO the_DT 0-h_NN control_NN ._SENT Similarly_RB ,_, as_RB published_VBN previously_RB U3_NP snoRNA_NP ,_, U6_NP snRNA_NP ,_, or_CC the_DT control_NN RNA_NP were_VBD stable_JJ through_IN 24_CD h._NN The_DT nucleolar_JJ localization_NN of_IN fluorescent_JJ U4_NP and_CC U5_NP snRNA_NP was_VBD specific_JJ ,_, because_IN injection_NN of_IN an_DT unrelated_JJ control_NN RNA_NP ,_, even_RB at_IN similar3_JJ times_NNS the_DT molar_JJ amount_NN of_IN U4_NP or_CC U5_NP ,_, did_VBD not_RB stain_VB nucleoli_NNS ._SENT Additional_JJ controls_NNS demonstrated_VBD that_IN the_DT observed_JJ fluorescent_JJ signals_NNS were_VBD not_RB due_JJ to_TO degradation_NN of_IN fluorescent_JJ snRNA_NN and_CC subsequent_JJ reutilization_NN of_IN the_DT label_NN by_IN other_JJ nuclear_JJ components_NNS ._SENT First_RB ,_, injection_NN of_IN a_DT similar75-fold_NN molar_JJ excess_NN of_IN fluorescein-UTP_NN alone_RB did_VBD not_RB label_VB the_DT nucleoli_NNS (_( Figure_NP a_DT )_) ._SENT Second_RB ,_, stability_NN assays_NNS using_VBG 32P-labeled_JJ transcripts_NNS demonstrated_VBD that_IN U4_NP and_CC U5_NP snRNA_NP transcripts_NNS were_VBD stable_JJ at_IN the_DT times_NNS the_DT nucleolar_JJ localization_NN assay_NN was_VBD performed_VBN (_( Figure_NN b_LS )_) ._SENT Similarly_RB ,_, as_IN previously_RB published_VBN for_IN U3_NP snoRNA_NP ,_, U6_NP snRNA_NP ,_, or_CC the_DT control_NN RNA_NP ,_, U4_NP and_CC U5_NP snRNAs_NNS were_VBD stable_JJ over_IN 24_CD h._JJ Sequences_NNS of_IN U6_NP snRNA_NP Essential_NP for_IN Nucleolar_NP Localization_NP |_SYM To_TO define_VB cis-acting_JJ elements_NNS of_IN U6_JJ snRNA_NNS necessary_JJ for_IN nucleolar_JJ localization_NN ,_, the_DT localization_NN of_IN mutant_JJ transcripts_NNS was_VBD compared_VBN with_IN that_DT of_IN wild_JJ type_NN ._SENT The_DT scheme_NN in_IN Figure_NP (_( modified_VBN from_IN and_CC )_) points_NNS out_IN areas_NNS of_IN functional_JJ interest_NN in_IN wild-type_NN U6_NP snRNA_NP and_CC also_RB gives_VBZ an_DT overview_NN of_IN the_DT various_JJ U6_NP mutants_NNS designed_VBN for_IN the_DT present_JJ study_NN ._SENT Sequences_NNS of_IN mature_JJ wild-type_NN U6_NP snRNA_NP and_CC of_IN the_DT mutants_NNS are_VBP listed_VBN in_IN detail_NN below_IN the_DT scheme_NN ._SENT Figure_NP 2_CD |_SYM Sequence_NN and_CC mutations_NNS of_IN U6_NP snRNA_NP ._SENT Sequence_NN and_CC mutations_NNS of_IN U6_NP snRNA_NP ._SENT The_DT sequence_NN of_IN Xenopus_NP U6_NP snRNA_NP ,_, which_WDT is_VBZ highly_RB conserved_VBN across_IN the_DT eukaryotic_JJ kingdom_NN ,_, is_VBZ shown_VBN ._SENT The_DT figure_NN has_VBZ been_VBN modified_VBN from_IN and_NP ._SENT Shaded_JJ areas_NNS are_VBP sites_NNS of_IN base_NN pairing_VBG with_IN U2_JJ snRNA_NN in_IN the_DT spliceosome_NN and_CC nt_RB 49_CD --_: 74_CD base_NN pairs_NNS with_IN U4_JJ snRNA_NN before_IN association_NN with_IN the_DT spliceosome_NN ._SENT Several_JJ of_IN the_DT modifications_NNS (_( psi_NN ,_, pseudouridine_NN ;_: m_NN ,_, methylated_VBD nucleotides_NNS )_) occur_VBP in_IN areas_NNS of_IN U6_NP snRNA_NN involved_VBN in_IN intermolecular_JJ base_NN pairing_VBG during_IN splicing_VBG ._SENT Most_JJS mutations_NNS designed_VBN for_IN this_DT study_NN were_VBD deletions_NNS covering_VBG the_DT nucleotides_NNS indicated_VBN by_IN lines_NNS ._SENT Delta1_NP --_: 19_CD was_VBD designed_VBN to_TO remove_VB the_DT 5'-terminal_JJ stem_NN ._SENT Nucleotides_NNS used_VBN for_IN substitution_NN of_IN nt_NN 20_CD --_: 25_CD ,_, which_WDT is_VBZ a_DT sequence_NN needed_VBN for_IN nuclear_JJ import_NN after_IN injection_NN of_IN U6_NP into_IN the_DT cytoplasm_NN ,_, are_VBP shown_VBN in_IN a_DT box_NN ._SENT In_IN various_JJ mutations_NNS of_IN the_DT middle_JJ part_NN of_IN the_DT molecule_NN ,_, sites_NNS of_IN base_NN pairing_VBG with_IN U2_NP and_CC U4_NP snRNA_NP were_VBD removed_VBN ._SENT In_IN addition_NN various_JJ deletions_NNS were_VBD introduced_VBN between_IN nt_JJ 82_CD and_CC 107_CD ,_, which_WDT includes_VBZ regions_NNS that_IN base_NN pair_NN in_IN the_DT spliceosome_NN with_IN U2_NP snRNA_NP as_RB well_RB as_IN the_DT 3_CD '_POS terminus_NN of_IN U6_NP that_WDT binds_VBZ the_DT La_NP protein_NN and_CC subsequently_RB the_DT Lsm_NN proteins_NNS (_( see_VB text_NN )_) ._SENT Furthermore_RB ,_, a_DT triple_JJ repeat_NN of_IN nt_NN 87_CD --_: 107_CD of_IN the_DT U6_NP 3_CD '_POS end_NN (_( 3_CD '_POS end_NN )_) was_VBD designed_VBN (_( open_JJ box_NN at_IN top_NN of_IN diagram_NN )_) ._SENT The_DT lower_JJR portion_NN of_IN this_DT figure_NN lists_VBZ the_DT sequences_NNS of_IN mutant_JJ U6_NP snRNAs_NNS ._SENT Nucleotides_NNS that_WDT are_VBP the_DT same_JJ as_RB in_IN wild-type_NP U6_NP are_VBP shown_VBN by_IN dots_NNS in_IN the_DT sequence_NN alignment_NN ,_, and_CC deletions_NNS are_VBP indicated_VBN by_IN dashes_NNS ._SENT There_EX is_VBZ no_DT previous_JJ information_NN at_IN which_WDT stage_NN of_IN its_PP$ life_NN cycle_NN U6_NP enters_VBZ nucleoli_NNS ._SENT It_PP might_MD enter_VB nucleoli_NNS as_IN the_DT individual_JJ snRNP_NN or_CC in_IN a_DT complex_NN as_IN a_DT di-snRNP_NN or_CC tri-snRNP_NN directly_RB bound_VBN to_TO U4_NP and_CC in_IN conjunction_NN with_IN U5_NP snRNA_NP ,_, both_DT of_IN which_WDT are_VBP also_RB found_VBN in_IN nucleoli_NNS (_( see_VB above_JJ ;_: Figure_NN a_DT )_) ._SENT Therefore_RB ,_, it_PP was_VBD of_IN particular_JJ interest_NN to_TO analyze_VB whether_IN the_DT sites_NNS in_IN U6_NP (_( nt_NN 49_CD --_: 74_LS )_) that_DT base_JJ pair_NN with_IN U4_NP before_IN association_NN with_IN the_DT spliceosome_NN and_CC that_WDT are_VBP important_JJ for_IN snRNP_NN assembly_NN might_MD play_VB a_DT role_NN in_IN U6_NP nucleolar_JJ localization_NN ._SENT However_RB ,_, deletions_NNS within_IN that_DT sequence_NN (_( Delta43_NP --_: 56_CD ,_, Delta57_NP --_: 81_CD ;_: Figure_NP )_) or_CC total_JJ deletion_NN of_IN the_DT entire_JJ middle_JJ part_NN of_IN the_DT molecule_NN ,_, including_VBG the_DT entire_JJ U4_NP binding_JJ site_NN (_( Delta43_NP --_: 81_CD ;_: Figure_NP )_) ,_, do_VBP not_RB appreciably_RB influence_VB nucleolar_JJ localization_NN of_IN U6_NP snRNA_NN compared_VBN with_IN the_DT wild_JJ type_NN ._SENT This_DT area_NN also_RB contains_VBZ all_DT sites_NNS for_IN nucleolar_JJ posttranscriptional_JJ methylation_NN of_IN U6_NP as_RB well_RB as_IN a_DT region_NN that_IN base_NN pairs_NNS with_IN U2_JJ snRNA_NN in_IN the_DT spliceosome_NN ._SENT Similarly_RB ,_, U6_NP snRNA_NP carrying_VBG a_DT deletion_NN of_IN the_DT 5_CD '_POS stem_NN (_( Delta1_NP --_: 19_LS )_) or_CC a_DT deletion_NN of_IN nt_NN 26_CD --_: 42_CD containing_VBG a_DT U2-binding_NP site_NN retained_VBD the_DT ability_NN to_TO localize_VB to_TO nucleoli_NNS ._SENT Therefore_RB ,_, areas_NNS of_IN U6_NP snRNA_NN that_WDT will_MD base_VB pair_NN with_IN U4_NP snRNA_NP or_CC later_RBR with_IN U2_JJ snRNA_NN during_IN splicing_VBG are_VBP not_RB required_VBN for_IN nucleolar_JJ localization_NN ._SENT Interestingly_RB ,_, a_DT deletion_NN or_CC substitution_NN of_IN nt_NN 20_CD --_: 25_CD does_VBZ not_RB affect_VB U6_NP nucleolar_JJ localization_NN ._SENT This_DT sequence_NN element_NN is_VBZ responsible_JJ for_IN nuclear_JJ import_NN of_IN U6_JJ snRNA_NN after_IN injection_NN into_IN the_DT cytoplasm_NN ._SENT Although_IN U6_NP during_IN maturation_NN normally_RB does_VBZ not_RB travel_VB to_TO the_DT cytoplasm_NN ,_, a_DT mutation_NN of_IN this_DT region_NN was_VBD used_VBN previously_RB to_TO study_VB the_DT effect_NN of_IN additional_JJ mutations_NNS on_IN the_DT natural_JJ nuclear_JJ retention_NN of_IN U6_NP by_IN preventing_VBG nuclear_JJ reimport_NN of_IN molecules_NNS leaking_VBG into_IN the_DT cytoplasm_NN ._SENT Figure_NP 3_CD |_SYM Nucleolar_JJ localization_NN of_IN U6_NP snRNA_NN mutated_VBN in_IN various_JJ positions_NNS throughout_IN the_DT molecule_NN ._SENT Nucleolar_JJ localization_NN of_IN U6_NP snRNA_NN mutated_VBN in_IN various_JJ positions_NNS throughout_IN the_DT molecule_NN ._SENT Fluorescein-labeled_NP U6_NP snRNA_NN mutants_NNS were_VBD injected_VBN into_IN the_DT nuclei_NNS of_IN X._NP laevis_NN oocytes_NNS and_CC 1.5_CD h_NN later_RBR the_DT localization_NN assay_NN performed_VBD ._SENT U6_NP snRNA_NP carrying_VBG a_DT deletion_NN of_IN the_DT 5_CD '_POS stem_NN (_( Delta1_NP --_: 19_LS )_) or_CC a_DT deletion_NN or_CC substitution_NN of_IN nt_NN 20_CD --_: 25_CD localized_VBN as_IN well_RB to_TO nucleoli_NNS as_IN the_DT wild-type_NN (_( WT_NP )_) molecule_NN (_( FL_NP ,_, green_JJ )_) ._SENT Similarly_RB ,_, various_JJ mutants_NNS with_IN deletions_NNS throughout_IN the_DT middle_JJ part_NN of_IN the_DT molecule_NN (_( Delta26_NP --_: 42_CD ,_, Delta43_NP --_: 56_CD ,_, Delta57_NP --_: 81_CD ,_, and_CC Delta43_NP --_: 81_LS )_) retained_VBN full_JJ ability_NN to_TO localize_VB to_TO nucleoli_NNS ._SENT In_IN contrast_NN ,_, a_DT deletion_NN of_IN nt_NN 82_CD --_: 107_CD completely_RB abolished_VBN nucleolar_JJ localization_NN ._SENT Other_JJ details_NNS as_IN in_IN Figure_NN a._NN In_IN contrast_NN to_TO the_DT mutations_NNS described_VBD above_JJ ,_, nucleolar_JJ localization_NN of_IN U6_NP could_MD be_VB completely_RB abolished_VBN by_IN a_DT deletion_NN of_IN nt_NN 82_CD --_: 107_CD of_IN U6_NP snRNA_NP ._SENT This_DT area_NN contains_VBZ the_DT 3_CD '_POS terminus_NN of_IN U6_NP ,_, which_WDT binds_VBZ the_DT La_NP protein_NN and_CC subsequently_RB the_DT Lsm_NN proteins_NNS (_( see_VB INTRODUCTION_NN )_) ._SENT The_DT 3'-terminal_JJ U_NP residues_NNS also_RB may_MD somewhat_RB assist_VB nuclear_JJ retention_NN of_IN U6_NP ,_, although_IN after_IN deletion_NN of_IN the_DT 3_CD '_POS end_NN the_DT majority_NN of_IN U6_NP injected_VBD into_IN Xenopus_NP oocytes_NNS still_RB remained_VBD in_IN the_DT nucleus_NN even_RB after_IN long_JJ incubation_NN times_NNS ._SENT The_DT present_JJ study_NN now_RB demonstrates_VBZ that_IN the_DT 3_CD '_POS end_NN of_IN U6_NP snRNA_NP is_VBZ essential_JJ for_IN nucleolar_JJ localization_NN ,_, whereas_IN the_DT remainder_NN of_IN the_DT molecule_NN representing_VBG more_JJR than_IN three-quarters_NNS of_IN the_DT U6_NP snRNA_NN sequence_NN ,_, including_VBG sites_NNS absolutely_RB required_VBN for_IN [_SYM U4/U6_NP ]_SYM di-snRNP_JJ formation_NN ,_, splicing_VBG complex_JJ assembly_NN ,_, and_CC splicing_VBG activity_NN ,_, lacks_VBZ elements_NNS important_JJ for_IN nucleolar_JJ localization_NN ._SENT In_IN additional_JJ control_NN experiments_NNS ,_, we_PP confirmed_VBD that_IN nucleolar_JJ localization_NN is_VBZ indeed_RB mediated_VBN independently_RB from_IN [_SYM U4/U6_NP ]_SYM snRNP_JJ assembly_NN because_IN 1_CD )_) the_DT synthetic_JJ U6_NP snRNA_NP and_CC U4_NP snRNA_NP transcripts_NNS generated_VBD here_RB by_IN in_IN vitro_NN transcription_NN retain_VB their_PP$ functional_JJ activity_NN to_TO form_VB a_DT [_SYM U4/U6_NP ]_SYM snRNP_NN ,_, 2_LS )_) the_DT mutant_JJ U6_NP Delta43_NP --_: 81_CD still_RB localizes_VBZ to_TO nucleoli_NNS even_RB though_IN it_PP lacks_VBZ the_DT U4_NP base-pairing_NN sites_NNS and_CC cannot_MD interact_VB with_IN U4_NP ,_, and_CC 3_LS )_) the_DT 3'-NoLE_JJ U6_NP mutant_NN that_WDT does_VBZ not_RB localize_VB to_TO nucleoli_NNS (_( Delta82_NP --_: 107_LS )_) is_VBZ still_RB able_JJ to_TO assemble_VB in_IN a_DT [_SYM U4/U6_NP ]_SYM snRNP_NN ._SENT The_DT experiments_NNS leading_VBG to_TO these_DT observations_NNS involved_VBD coinjection_NN of_IN U6_NP snRNA_NP (_( colabeled_VBN with_IN [_SYM 32P]UTP_JJ and_CC fluorescein-UTP_JJ )_) with_IN U4_NP snRNA_NP transcripts_NNS (_( labeled_VBN with_IN fluorescein-UTP_NN )_) into_IN U6-_NP and_CC U4-depleted_NP Xenopus_NP oocytes_NNS and_CC subsequent_JJ coimmunoprecipitation_NN of_IN these_DT snRNAs_NNS with_IN an_DT anti-Sm_NN antibody_NN ._SENT Because_IN the_DT Sm_NP proteins_NNS are_VBP bound_VBN to_TO U4_NP and_CC not_RB to_TO U6_NP snRNA_NP ,_, precipitation_NN of_IN U6_NP occurs_VBZ only_RB if_IN it_PP is_VBZ associated_VBN with_IN U4_NP snRNA_NP ;_: this_DT technique_NN was_VBD used_VBN by_IN to_TO identify_VB domains_NNS of_IN U4_NP and_CC U6_NP required_VBD for_IN snRNP_NN assembly_NN ._SENT Figure_NN shows_VBZ that_IN U6_NP WT_NP and_CC the_DT NoLE_NP 3'-mutant_JJ (_( Delta82_NP --_: 107_LS )_) but_CC not_RB U6_NP mutated_VBD in_IN nt_RB 43_CD --_: 81_CD were_VBD coprecipitated_VBN with_IN U4_NP when_WRB using_VBG an_DT anti-Sm_NN antibody_NN ._SENT Moreover_RB ,_, in_IN the_DT converse_JJ experiment_NN ,_, U4_NP carrying_VBG a_DT deletion_NN of_IN the_DT base-pairing_NN sites_NNS for_IN U6_NP (_( Delta1_NP --_: 18/56_CD --_: 63_LS )_) failed_VBN to_TO precipitate_VB wild-type_NN U6_NP snRNA_NP ._SENT Figure_NP 4_CD |_SYM [_SYM U4/U6_NP ]_SYM snRNP_JJ assembly_NN after_IN nuclear_JJ injection_NN ._SENT [_SYM U4/U6_NP ]_SYM snRNP_JJ assembly_NN after_IN nuclear_JJ injection_NN ._SENT U6_NP snRNA_NP (_( colabeled_VBN with_IN [_SYM 32P]UTP_JJ and_CC fluorescein-UTP_JJ )_) and_CC U4_NP snRNA_NP transcripts_NNS (_( labeled_VBN with_IN fluorescein-UTP_NN )_) were_VBD coinjected_VBN into_IN Xenopus_NP oocytes_NNS depleted_VBN of_IN endogenous_JJ U4_NP and_CC U6_NP snRNA_NP ._SENT After_IN 4_CD h_NN of_IN incubation_NN the_DT functional_JJ ability_NN of_IN the_DT in_IN vitro_NN transcripts_NNS to_TO form_VB a_DT [_SYM U4/U6_NP ]_SYM snRNP_NN was_VBD analyzed_VBN by_IN immunoprecipitation_NN from_IN the_DT nuclear_JJ lysate_NN with_IN an_DT anti-Sm_NN protein_NN antibody_NN ._SENT The_DT equivalents_NNS of_IN 10_CD nuclei/sample_NN of_IN the_DT precipitated_VBN RNA_NP (_( pellet_NN )_) and_CC 0.1_CD nuclei/sample_NN of_IN the_DT supernatant_JJ (_( control_NN for_IN equal_JJ amounts_NNS injected_VBD )_) were_VBD analyzed_VBN on_IN a_DT denaturing_VBG 8_CD %_NN polyacrylamide_NN ,_, 8_CD M_NP urea_NN gel_NN and_CC by_IN autoradiography_NN ._SENT [_SYM U4/U6_NP ]_SYM snRNP_NN assembly_NN occurs_VBZ between_IN wild-type_NN U6_NP snRNA_NP (_( U6_NP WT_NP )_) and_CC wild-type_NP U4_NP snRNA_NP (_( U4_NP WT_NP )_) ,_, also_RB with_IN the_DT U6_NP NoLE_NP mutant_NN (_( Delta82_NP --_: 107_LS )_) ,_, and_CC even_RB with_IN the_DT truncated_JJ 3'end_JJ mutant_NN (_( Delta82-107_JJ )_) ,_, consistent_JJ with_IN ._SENT Ability_NN of_IN the_DT transcripts_NNS to_TO form_VB a_DT snRNP_NN was_VBD disrupted_VBN by_IN using_VBG either_DT mutant_JJ U6_NP (_( Delta43_NP --_: 81_LS )_) or_CC mutant_JJ U4_NP (_( Delta1_NP --_: 18/Delta56_NP --_: 63_LS )_) that_WDT lack_VBP the_DT sites_NNS to_TO base_JJ pair_NN with_IN each_DT other_JJ and_CC that_WDT are_VBP important_JJ for_IN snRNP_NN assembly_NN before_IN association_NN with_IN the_DT spliceosome_NN ._SENT It_PP is_VBZ notable_JJ that_IN this_DT U6_NP mutant_NN (_( Delta43_NP --_: 81_LS )_) is_VBZ still_RB capable_JJ of_IN localizing_VBG to_TO nucleoli_NNS (_( see_VB Figure_NN )_) ._SENT None_NN of_IN the_DT samples_NNS were_VBD precipitated_VBN by_IN beads_NNS coupled_VBN to_TO control_VB antibody_NN ._SENT Although_IN not_RB the_DT primary_JJ focus_NN of_IN the_DT present_JJ study_NN ,_, we_PP also_RB analyzed_VBD association_NN of_IN U6_NP with_IN Cajal_NP bodies_NNS ,_, identified_VBN by_IN their_PP$ immunostaining_NN for_IN coilin_NN ._SENT One_CD hour_NN after_IN nuclear_JJ injection_NN of_IN fluorescein-labeled_JJ wild-type_NN U6_NP snRNA_NP ,_, the_DT Cajal_NP bodies_NNS are_VBP stained_VBN ,_, although_IN not_RB as_RB strongly_RB as_IN nucleoli_NNS ._SENT Four_CD hours_NNS after_IN injection_NN ,_, consistent_JJ with_IN the_DT previously_RB reported_VBN kinetics_NNS of_IN nucleolar_JJ localization_NN of_IN U6_NP snRNA_NP ,_, the_DT nucleoli_NNS are_VBP weakly_RB stained_VBN ._SENT At_IN this_DT time_NN point_NN ,_, Cajal_JJ body_NN staining_VBG by_IN U6_NP snRNA_NP remains_VBZ at_IN low_JJ levels_NNS (_( our_PP$ unpublished_JJ data_NNS )_) ._SENT It_PP has_VBZ been_VBN reported_VBN that_IN snoRNA_NN lacking_VBG the_DT box_NN C/D_NP NoLE_NP accumulates_VBZ in_IN Cajal_JJ bodies_NNS ,_, and_CC so_RB we_PP investigated_VBD whether_IN a_DT similar_JJ phenomenon_NN occurred_VBN for_IN U6_NP snRNA_NP ._SENT However_RB ,_, U6_NP snRNA_NP lacking_VBG its_PP$ NoLE_NN no_RB longer_RBR localized_JJ to_TO Cajal_JJ bodies_NNS or_CC nucleoli_NNS ._SENT Therefore_RB ,_, the_DT 3'-end_JJ of_IN U6_NP snRNA_NP is_VBZ essential_JJ not_RB only_RB for_IN localization_NN to_TO nucleoli_NNS but_CC also_RB to_TO Cajal_JJ bodies_NNS ._SENT Figure_NP 5_CD |_SYM The_DT 3_CD '_POS end_NN of_IN U6_NP is_VBZ essential_JJ for_IN localization_NN to_TO Cajal_JJ bodies_NNS ._SENT The_DT 3_CD '_POS end_NN of_IN U6_NP is_VBZ essential_JJ for_IN localization_NN to_TO Cajal_JJ bodies_NNS ._SENT Fluorescein-labeled_JJ wild-type_NN U6_NP snRNA_NP as_RB well_RB as_IN the_DT 3_CD '_POS mutant_NN (_( Delta82_NP --_: 107_LS )_) were_VBD injected_VBN into_IN the_DT nuclei_NNS of_IN Xenopus_NP oocytes_NNS and_CC the_DT localization_NN assay_NN performed_VBD ._SENT Immunostaining_VBG of_IN Cajal_JJ bodies_NNS (_( CB_NP ,_, red_JJ )_) was_VBD carried_VBN out_RP in_IN addition_NN to_TO DNA_NP staining_VBG of_IN nucleoli_NNS (_( DAPI_NP ,_, blue_JJ )_) to_TO distinguish_VB between_IN these_DT two_CD sites_NNS of_IN U6_NP snRNA_NP localization_NN (_( FL_NP ,_, green_JJ )_) ._SENT Injection_NN of_IN wild-type_JJ U6_NP snRNA_NN results_NNS in_IN strong_JJ labeling_VBG of_IN nucleoli_NNS and_CC weaker_JJR labeling_VBG of_IN Cajal_NP bodies_NNS 1_CD h_NN after_IN injection_NN ._SENT In_IN contrast_NN ,_, deletion_NN of_IN the_DT U6_NP 3_CD '_POS end_NN (_( Delta82_NP --_: 107_LS )_) completely_RB abolished_VBD localization_NN to_TO nucleoli_NNS as_IN well_RB as_RB to_TO Cajal_JJ bodies_NNS ,_, comparable_JJ with_IN background_NN levels_NNS seen_VBN in_IN uninjected_JJ control_NN oocytes_NNS (_( no_DT injection_NN )_) ._SENT Other_JJ details_NNS as_IN in_IN Figure_NP a._NP Further_NP mutational_JJ analysis_NN was_VBD carried_VBN out_RP to_TO reveal_VB whether_IN specific_JJ sequences_NNS of_IN a_DT few_JJ nucleotides_NNS within_IN the_DT 3_CD '_POS part_NN of_IN U6_NP are_VBP essential_JJ for_IN nucleolar_JJ localization_NN ,_, similar_JJ to_TO the_DT discrete_JJ NoLEs_NNS of_IN snoRNAs_NNS ._SENT Four_CD mutations_NNS were_VBD designed_VBN that_WDT spanned_VBD the_DT region_NN of_IN interest_NN in_IN U6_NP snRNA_NP (_( Delta82_NP --_: 95_CD ,_, Delta96_NP --_: 99_CD ,_, Delta100_NP --_: 102_CD ,_, and_CC Delta103_NP --_: 107_LS )_) ._SENT In_IN addition_NN ,_, a_DT mutation_NN spanning_VBG the_DT last_JJ 8_CD nt_NNS (_( Delta100_NP --_: 107_LS )_) was_VBD used_VBN ,_, which_WDT drastically_RB decreased_VBD the_DT interaction_NN of_IN U6_NP with_IN the_DT La_NP protein_NN in_IN Xenopus_NP oocytes_NNS ._SENT All_DT five_CD mutations_NNS of_IN the_DT 3_CD '_POS end_NN of_IN U6_NP (_( Delta82_NP --_: 95_CD ,_, Delta96_NP --_: 99_CD ,_, Delta100_NP --_: 102_CD ,_, Delta103_NP --_: 107_CD ,_, and_CC Delta100_NP --_: 107_LS )_) significantly_RB impaired_JJ localization_NN ._SENT However_RB ,_, weak_JJ fluorescent_JJ signals_NNS were_VBD still_RB obtained_VBN by_IN all_DT five_CD U6_NP mutants_NNS and_CC localization_NN was_VBD not_RB entirely_RB abolished_VBN ._SENT This_DT is_VBZ in_IN contrast_NN to_TO the_DT U6_NP mutant_NN ,_, which_WDT lacks_VBZ the_DT entire_JJ 3_CD '_POS end_NN (_( Delta82_NP --_: 107_LS )_) and_CC which_WDT was_VBD entirely_RB incapable_JJ of_IN localization_NN to_TO nucleoli_NNS ._SENT Therefore_RB ,_, nucleolar_JJ localization_NN of_IN U6_NP snRNA_NP relies_VBZ on_IN many_JJ nucleotides_NNS in_IN the_DT 3'-end_JJ region_NN ,_, rather_RB than_IN on_IN just_RB a_DT few_JJ nucleotides_NNS ._SENT Figure_NP 6_CD |_SYM Sequences_NNS within_IN the_DT 3_CD '_POS end_NN of_IN U6_JJ snRNA_NNS that_WDT mediate_VBP nucleolar_JJ localization_NN ._SENT Sequences_NNS within_IN the_DT 3_CD '_POS end_NN of_IN U6_JJ snRNA_NNS that_WDT mediate_VBP nucleolar_JJ localization_NN ._SENT Mutational_JJ analysis_NN of_IN the_DT 3_CD '_POS portion_NN of_IN U6_NP snRNA_NP was_VBD carried_VBN out_RP to_TO analyze_VB whether_IN specific_JJ sequences_NNS within_IN this_DT region_NN are_VBP essential_JJ for_IN nucleolar_JJ localization_NN ._SENT Various_JJ deletion_NN mutants_NNS of_IN the_DT 3_CD '_POS end_NN of_IN U6_NP (_( Delta82_NP --_: 95_CD ,_, Delta96_NP --_: 99_CD ,_, Delta100_NP --_: 102_CD ,_, Delta103_NP --_: 107_CD ,_, and_CC Delta100_NP --_: 107_LS )_) were_VBD impaired_VBN in_IN their_PP$ nucleolar_JJ localization_NN 1.5_CD h_NN after_IN injection_NN ._SENT However_RB ,_, they_PP still_RB labeled_VBD nucleoli_NNS weakly_RB ,_, unlike_IN the_DT larger_JJR deletion_NN of_IN the_DT 3_CD '_POS end_NN of_IN U6_NP (_( Delta82_NP --_: 107_CD ;_: Figure_NP )_) that_WDT had_VBD no_DT nucleolar_JJ signal_NN ._SENT Therefore_RB ,_, 